Jupiter Wellness Inc. (JUPW)
1.52
0.16 (11.76%)
At close: Sep 14, 2023, 8:00 PM
11.76% (1D)
| Bid | n/a |
| Market Cap | 49.33M |
| Revenue (ttm) | 5.3M |
| Net Income (ttm) | -11.71M |
| EPS (ttm) | -0.63 |
| PE Ratio (ttm) | -2.4126984126984126 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 1,970,467 |
| Avg. Volume (20D) | 1,020,340 |
| Open | 1.39 |
| Previous Close | 1.36 |
| Day's Range | 1.33 - 1.54 |
| 52-Week Range | 0.30 - 1.64 |
| Beta | 0.28 |
About JUPW
Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufact...
Sector Healthcare
IPO Date Oct 30, 2020
Employees 10
Stock Exchange NASDAQ
Ticker Symbol JUPW
Website https://www.jupiterwellness.com